Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport (original) (raw)
Olefsky, J.M. & Courtney, C.H. Type 2 diabetes mellitus: etiology, pathogenesis and natural history. in Endocrinology 5th edn (eds. DeGroot, L.J. et al.) 1093–1117 (W.B. Saunders, 2005). Google Scholar
Korner, J., Woods, S.C. & Woodworth, K.A. Regulation of energy homeostasis and heath consequences in obesity. Am. J. Med.122, S12–S18 (2009). ArticlePubMed Google Scholar
Parillo, M. & Ricardi, G. Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence. Br. J. Nutr.92, 7–19 (2004). ArticleCASPubMed Google Scholar
Surwit, R.S., Kuhn, C.M., Cochrane, C., McCubbin, J.A. & Feinglos, M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes37, 1163–1167 (1988). ArticleCASPubMed Google Scholar
Kahn, S.E. The relative contribution of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia46, 3–19 (2003). ArticleCASPubMed Google Scholar
Winzell, M.S. & Ahren, B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes53 (suppl. 3) S215–S219 (2004). ArticlePubMed Google Scholar
Leroith, D. & Accili, D. Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes. Nat. Clin. Pract. Endocrinol. Metab.4, 164–172 (2008). ArticleCASPubMedPubMed Central Google Scholar
Saltiel, A.R. & Kahn, C.R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature414, 799–806 (2001). ArticleCASPubMed Google Scholar
Schenk, S., Saberi, M. & Olefsky, J.M. Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest.118, 2992–3002 (2008). ArticleCASPubMedPubMed Central Google Scholar
Reaven, G.M. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu. Rev. Nutr.25, 391–406 (2005). ArticleCASPubMed Google Scholar
Johnson, J.H. et al. Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes. Science250, 546–549 (1990). ArticleCASPubMed Google Scholar
Orci, L. et al. Evidence that down-regulation of β-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia. Proc. Natl. Acad. Sci. USA87, 9953–9957 (1990). ArticleCASPubMedPubMed Central Google Scholar
Thorens, B., Weir, G., Leahy, J.L., Lodish, H.F. & Bonner-Weir, S. Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats. Proc. Natl. Acad. Sci. USA87, 6492–6496 (1990). ArticleCASPubMedPubMed Central Google Scholar
Unger, R.H. Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells. Science251, 1200–1205 (1991). ArticleCASPubMed Google Scholar
Valera, A. et al. Expression of GLUT2 antisense RNA in β cells of transgenic mice leads to diabetes. J. Biol. Chem.269, 28543–28546 (1994). CASPubMed Google Scholar
Gremlich, S., Roduit, R. & Thorens, B. Dexamethasone induces posttranslational degradation of GLUT2 and inhibition of insulin secretion in isolated pancreatic β cells. J. Biol. Chem.272, 3216–3222 (1997). ArticleCASPubMed Google Scholar
Guillam, M.T. et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat. Genet.17, 327–330 (1997). ArticleCASPubMed Google Scholar
Guillam, M.-T., Dupraz, P. & Thorens, B. Glucose uptake, utilization, and signaling in GLUT2-null islets. Diabetes49, 1485–1491 (2000). ArticleCASPubMed Google Scholar
Reimer, M.K. & Ahrén, B. Altered β-cell distribution of pdx-1 and GLUT2 after a short-term challenge with a high-fat diet in C57BL/6J mice. Diabetes51, S138–S143 (2002). ArticleCASPubMed Google Scholar
Del Guerra, S. et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes54, 727–735 (2005). ArticleCASPubMed Google Scholar
Kahn, S.E., Hull, R.L. & Utzschneider, K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature444, 840–846 (2006). ArticleCASPubMed Google Scholar
Ohtsubo, K. et al. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell123, 1307–1321 (2005). ArticleCASPubMed Google Scholar
Minowa, M.T. et al. cDNA cloning and expression of bovine UDP-_N_-acetylglucosamine:α1,3-_D_-mannoside β1,4-_N_-acetylglucosaminyltransferase IV. J. Biol. Chem.273, 11556–11562 (1998). ArticleCASPubMed Google Scholar
De Vos, A. et al. Human and rat beta cells differ in glucose transporter but not glucokinase gene expression. J. Clin. Invest.96, 2489–2495 (1995). ArticleCASPubMedPubMed Central Google Scholar
Thorens, B., Guillam, M.T., Beermann, F., Burcelin, R. & Jaqueet, M. Transgenic overexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion. J. Biol. Chem.275, 23751–23758 (2000). ArticleCASPubMed Google Scholar
Alessi, D.R. & Cohen, P. Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev.8, 55–62 (1998). ArticleCASPubMed Google Scholar
White, M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab.283, E413–E422 (2002). ArticleCASPubMed Google Scholar
Rossmeisl, M., Rim, J.S., Koza, R.A. & Kozak, L.P. Variation in type 2 diabetes-related traits in mouse strains susceptible to diet-induced obesity. Diabetes52, 1958–1966 (2003). ArticleCASPubMed Google Scholar
Poitout, V. & Robertson, R.P. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr. Rev.29, 351–366 (2008). ArticleCASPubMed Google Scholar
Kebede, M.A., Alquier, T., Latour, M.G. & Poitout, V. Lipid receptors and islet function: therapeutic implications? Diabetes Obes. Metab.11 (suppl. 4) 10–20 (2009). ArticleCASPubMedPubMed Central Google Scholar
Unger, R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes44, 863–870 (1995). ArticleCASPubMed Google Scholar
Gremlich, S., Bonny, C., Waeber, G. & Thorens, B. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J. Biol. Chem.272, 30261–30269 (1997b). ArticleCASPubMed Google Scholar
Wolfrum, C., Asilmaz, E., Luca, E., Friedman, J.M. & Stoffel, M. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature432, 1027–1032 (2004). ArticleCASPubMed Google Scholar
Chen, Y.W. et al. The role of phosphoinositide 3-kinase/Akt signaling in low-dose mercury-induced mouse pancreatic beta-cell dysfunction in vitro and in vivo. Diabetes55, 1614–1624 (2006). ArticleCASPubMed Google Scholar
Gao, N. et al. Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-cell. Mol. Endocrinol.24, 1594–1604 (2010). ArticleCASPubMedPubMed Central Google Scholar
Mitchell, S.M. & Frayling, T.M. The role of transcription factors in maturity-onset diabetes of the young. Mol. Genet. Metab.77, 35–43 (2002). ArticleCASPubMed Google Scholar
Fukui, K. et al. The HNF-1 target collection controls insulin exocytosis by SNARE complex formation. Cell Metab.2, 373–384 (2005). ArticleCASPubMed Google Scholar
Gunton, J.E. et al. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell122, 337–349 (2005). ArticleCASPubMed Google Scholar
Ohtsubo, K. & Marth, J.D. Glycosylation in cellular mechanisms of health and disease. Cell126, 855–867 (2006). ArticleCASPubMed Google Scholar
Rabinovich, G.A., Toscano, M.A., Jackson, S.S. & Vasta, G.R. Functions of cell surface galectin-glycoprotein lattices. Curr. Opin. Struct. Biol.17, 513–520 (2007). ArticleCASPubMedPubMed Central Google Scholar
Scarlett, J.A., Gray, R.S., Griffin, J., Olefsky, J.M. & Kolterman, O.G. Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care5, 353–363 (1982). ArticleCASPubMed Google Scholar
Revers, R.R., Kolterman, O.G., Scarlett, J.A., Gray, R.S. & Olefsky, J.M. Lack of in vivo insulin resistance in controlled insulin-dependent, type I, diabetic patients. J. Clin. Endocrinol. Metab.58, 353–358 (1984). ArticleCASPubMed Google Scholar
Garvey, W.T., Olefsky, J.M., Griffin, J., Hamman, R.F. & Kolterman, O.G. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes34, 222–234 (1985). ArticleCASPubMed Google Scholar
Pillay, T.S., Xiao, S. & Olefsky, J.M. Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites. J. Clin. Invest.97, 613–620 (1996). ArticleCASPubMedPubMed Central Google Scholar
Shafi, R. et al. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. USA97, 5735–5739 (2000). ArticleCASPubMedPubMed Central Google Scholar
Cousin, S.P. et al. Free fatty acid–induced inhibition of glucose and insulin-like growth factor I–induced deoxyribonucleic acid synthesis in the pancreatic β-cell line INS-1. Endocrinology142, 229–240 (2001). ArticleCASPubMed Google Scholar